Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new era in atherothrombosis.

Atherosclerosis·2026
Same author

European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment.

European heart journal. Quality of care & clinical outcomes·2022
Same author

The ESC Working Group on Cardiovascular Regenerative and Reparative Medicine.

European heart journal·2020
Same author

Circulating microparticles are associated with clinical severity of persistent ST-segment elevation myocardial infarction complicated with cardiogenic shock.

International journal of cardiology·2018
Same author

Tissue factor variants induce monocyte transformation and transdifferentiation into endothelial cell-like cells.

Journal of thrombosis and haemostasis : JTH·2017
Same author

LRP5/canonical Wnt signalling and healing of ischemic myocardium.

Basic research in cardiology·2016
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Circulating biomarkers.

L Badimon1, J C Romero, J Cubedo

  • 1Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain. lbadimon@csic-iccc.org

Thrombosis Research
|October 3, 2012
PubMed
Summary
This summary is machine-generated.

New biomarkers aid in preventing cardiovascular diseases (CVD) by identifying at-risk individuals and monitoring disease progression. This review explores recently discovered CVD biomarkers and their clinical applications for improved diagnosis and prognosis.

More Related Videos

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR
07:37

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR

Published on: June 26, 2016

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Related Experiment Videos

Last Updated: May 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR
07:37

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR

Published on: June 26, 2016

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Preventive Medicine

Background:

  • Cardiovascular diseases (CVD) are a major global cause of mortality.
  • Emerging biomarkers offer potential for primary CVD prevention and risk stratification.
  • Current biomarkers include inflammatory, endothelial, neurohormonal, ischemia, and necrosis markers.

Purpose of the Study:

  • To review recently discovered biomarkers for cardiovascular diseases.
  • To discuss the clinical applications of these novel biomarkers.
  • To highlight the importance of new biomarkers for enhancing CVD diagnosis and prognosis.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies on novel cardiovascular biomarkers.
  • Synthesis of information on clinical utility and applications.

Main Results:

  • Several new biomarkers show promise in CVD risk assessment.
  • Biomarkers are crucial for identifying individuals at risk and monitoring disease.
  • Novel markers can improve diagnostic and prognostic accuracy in CVD.

Conclusions:

  • Continued research into novel biomarkers is essential for advancing CVD prevention.
  • Biomarkers play a vital role in personalized cardiovascular risk management.
  • The clinical application of new biomarkers promises to enhance patient outcomes in CVD.